Healthcare -
Biotechnology - NASDAQ - US
$ 29.935
0.69 %
$ 3.72 B
Market Cap
-14.75
P/E
APLS - OTHER CURRENT ASSETS
Other Current Assets APLS - Apellis Pharmaceuticals, Inc.
61.2 M
LAST VALUE
-20.60%
2 YEAR CAGR
18.53%
5 YEAR CAGR
66.91%
10 YEAR CAGR